Use of vasopeptidase inhibitors to treat or slow the progression of cognitive dysfunction and to treat and/or prevent dementia

摘要

Vasopeptidase inhibitors, especially omapatrilat, are useful in treating and/or slowing the progression of cognitive dysfunction and treating and/or preventing dementia of the Alzheimer's type and vascular dementia. The vasopeptidase inhibitor may be used in combination with other pharmaceutically active agents.